Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;80(2):1047-52.
doi: 10.1128/JVI.80.2.1047-1052.2006.

Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source

Affiliations

Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source

Melissa J Churchill et al. J Virol. 2006 Jan.

Abstract

We studied the evolution of human immunodeficiency virus type 1 (HIV-1) in a cohort of long-term survivors infected with an attenuated strain of HIV-1 acquired from a single source. Although the cohort members experienced differing clinical courses, we demonstrate similar evolution of HIV-1 nef/long-terminal repeat (LTR) sequences, characterized by progressive sequence deletions tending toward a minimal nef/LTR structure that retains only sequence elements required for viral replication. The in vivo pathogenicity of attenuated HIV-1 is therefore dictated by viral and/or host factors other than those that impose a unidirectional selection pressure on the nef/LTR region of the HIV-1 genome.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Analysis of SBBC nef/LTR sequence. (A) Schematic representation of nef/LTR sequence deletions of HIV-1 cloned from the earliest available PBMC samples. The data shown represent a consensus of at least 20 independent nef/LTR sequences cloned from each PBMC sample. The genomic structures are compared to wild-type HIV-1 (NL4-3). Numbers refer to nucleotide positions in NL4-3. Black blocks represent intact sequence, and gaps represent deletions. Gray blocks represent the sequence area containing duplicated and rearranged NF-κB and Sp-1 binding sites in the LTR. The dates shown represent the times when PBMC were collected for analysis. (B) More-detailed analysis of the LTR, depicting transcription factor binding sites. PPT, polypurine tract; NRE, negative regulatory element.
FIG. 2.
FIG. 2.
Evolution of SBBC nef/LTR sequence deletions. Schematic representation of nef/LTR sequence deletions of HIV-1 cloned from longitudinally collected PBMC samples from SBBC long-term nonprogressors (A) and slow progressors (B). The data shown represent a consensus of at least 20 independent nef/LTR sequences cloned from each PBMC sample. The genomic structures are compared to wild-type HIV-1 (NL4-3). Numbers refer to nucleotide positions in NL4-3. Black blocks represent intact sequence, and gaps represent deletions. Gray blocks represent the sequence area containing duplicated and rearranged NF-κB and Sp-1 binding sites in the LTR. The dates shown represent the times when PBMC were collected for analysis. PPT, polypurine tract; NRE, negative regulatory element.
FIG. 3.
FIG. 3.
Convergent evolution of SBBC nef/LTR sequences to a minimal nef/LTR structure. Comparisons of the genomic structures of nef/LTR sequences cloned from the earliest available and most recently obtained PBMC samples are shown. The genomic structures are compared to those of wild-type HIV-1 (NL4-3). Numbers refer to nucleotide positions in NL4-3. Black blocks represent intact sequence, and gaps represent deletions. Gray blocks represent the sequence area containing duplicated and rearranged NF-κB and Sp-1 binding sites in the LTR. The dates shown represent the times when PBMC were collected for analysis. PPT, polypurine tract; NRE, negative regulatory element.

Similar articles

Cited by

References

    1. Alexander, L., P. O. Illyinskii, S. M. Lang, R. E. Means, J. Lifson, K. Mansfield, and R. C. Desrosiers. 2003. Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J. Virol. 77:6823-6835. - PMC - PubMed
    1. Birch, M. R., J. C. Learmont, W. B. Dyer, N. J. Deacon, J. J. Zaunders, N. Saksena, A. L. Cunningham, J. Mills, and J. S. Sullivan. 2001. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J. Clin. Virol. 22:263-270. - PubMed
    1. Chakrabarti, L., V. Baptiste, E. Khatissian, M. C. Cumont, A. M. Aubertin, L. Montagnier, and B. Hurtrel. 1995. Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology 213:535-548. - PubMed
    1. Churchill, M., J. Sterjovski, L. Gray, D. Cowley, C. Chatfield, J. Learmont, J. S. Sullivan, S. M. Crowe, J. Mills, B. J. Brew, S. L. Wesselingh, D. A. McPhee, and P. R. Gorry. 2004. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. J. Infect. Dis. 190:2181-2186. - PubMed
    1. Crowe, S. M., D. D. Ho, D. Marriott, B. Brew, P. R. Gorry, J. S. Sullivan, J. Learmont, and J. Mills. 2005. In vivo replication kinetics of a nef-deleted strain of HIV-1. AIDS 19:842-843. - PubMed

Publication types

Substances

Associated data